Posted on

“A ‘tough-on-crime’ position is important to this administration, and your efforts to curb the importation of drugs into America are laudable. While we must continue our fight against organized crime and drug-related violence, it is our opinion that medical marijuana research falls outside of those categories, and does not pose a pressing danger to American society.”

A bi-partisan group of congresspersons sent a concerned letter to Attorney General Jeff Sessions in light of allegations that the Department of Justice is blocking medical marijuana research.

The letter came from Representatives Matt Gaetz, R-Florida; Dana Rohrabacher, R-California; Jared Polis, D-Colorado; and Earl Blumenauer, D-Oregon, all of whom were concerned that last year’s relaxation on MMJ research seems to be going ignored. Though over two dozen proposals to research medical cannabis have been sent to the DOJ for approval, they haven’t been touched: neither green-lighted or denied, the proposals sit in some sort of bureaucratic purgatory. Many are concerned that this isn’t a coincidence.

It’s well known that our Attorney General doesn’t like cannabis–medicinal or otherwise. So when a Department of Justice that cites leaked, old, or irrelevant data in concerns about states’ compliance with federal guidelines, it doesn’t seem like too much of a coincidence that they’re also holding up valuable research that could help inform regulations that already exist in most states, regardless of federal approval.

“It is worrisome to think that the Department of Justice, the cornerstone of American civil society, would limit new and potentially groundbreaking research simply because it does not want to follow a rule,” the lawmakers stated in their letter to Sessions late last month. “We write to inquire whether the allegations raised by the Post are true, and, if so, to understand the Department of Justice’s rationale in refusing to process these applications.”

As cited by the Congress members, over eighty percent of American citizens believe that doctor-prescribed medical marijuana should be legal. People from all over the political spectrum support legalization of MMJ; weed is no longer simply a “liberal thing”. In the face of the data, what excuse could possibly be made by the Administration to defend these kinds of roadblocks?